(Q42977691)

12 November 2017

IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection (English)

1 reference

12 November 2017

1 reference

1 reference

H-Y Rao

1

1 reference

12 November 2017

D-G Sun

2

1 reference

12 November 2017

D Jiang

3

1 reference

12 November 2017

R-F Yang

4

1 reference

12 November 2017

F Guo

5

1 reference

12 November 2017

J-H Wang

6

1 reference

12 November 2017

F Liu

7

1 reference

12 November 2017

H-Y Zhang

8

1 reference

12 November 2017

H-H Zhang

9

1 reference

12 November 2017

S-C Du

10

1 reference

12 November 2017

Q Jin

11

1 reference

12 November 2017

H Qin

12

1 reference

12 November 2017

A-S-F Lok

13

1 reference

12 November 2017

L Wei

14

1 reference

12 November 2017

4 August 2011

1 reference

Journal of Viral Hepatitis

12 November 2017

1 reference

12 November 2017

19

1 reference

12 November 2017

3

1 reference

12 November 2017

173-181

1 reference

Natural history of chronic hepatitis C virus infection.

12 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01497.X

The burden of hepatitis C in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01497.X

Global burden of disease (GBD) for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01497.X

Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01497.X

Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01497.X

Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01497.X

Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01497.X

The natural history of hepatitis C virus infection: host, viral, and environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01497.X

Impact of aboriginal ethnicity on HCV core-induced IL-10 synthesis: interaction with IL-10 gene polymorphisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01497.X

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01497.X

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01497.X

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01497.X

Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01497.X

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01497.X

Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01497.X

A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01497.X

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01497.X

Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01497.X

Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01497.X

Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01497.X

Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2011.01497.X

10.1111/J.1365-2893.2011.01497.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference